NDC 51672-4136-07 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4136
- Requested NDC
- 51672-4136-07
- Package NDCs from labels
- 51672-4136-7, 51672-4136-9, 51672-4136-0, 51672-4136-07
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2026-03-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2026-03-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4136-0 | Levetiracetam | 3785 mL in 1 BOTTLE | SOLUTION | 3785 | 15 | |
| 51672-4136-7 | Levetiracetam | 100 mL in 1 BOTTLE | SOLUTION | 100 | 15 | |
| 51672-4136-9 | Levetiracetam | 473 mL in 1 BOTTLE | SOLUTION | 473 | 15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4136 | LEVETIRACETAM TABLET, FILM COATED LEVETIRACETAM SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.] | 12 | Current NDC, Legacy NDC, 3 package rows | 20200723_bf412e94-ca36-4da9-83d7-fb0f1323cf21.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4136-9 | ML - Milliliter | 51672-4136 | e160738e-4508-4a32-b72e-4b74171d8acd | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cetaphil Daily Facial Moisturizer with suncreen SPF 50 | OCTINOXATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE, TITANIUM DIOXIDE | Galderma Laboratories, L.P. | 6650d137-e69e-4ec2-8311-3de74bf21315 | 2024-04-17 | Warnings | 15FIX9V2JP |
| SPF 30 Mineral Sunscreen Cariposa | TITANIUM DIOXIDE, ZINC OXIDE | Talent Brands Company LLC | 0bc21573-d302-4d85-8d8f-dca9a48e1f35 | 2024-04-17 | Warnings | 15FIX9V2JP |
| Levetiracetam in Sodium Chloride | LEVETIRACETAM IN SODIUM CHLORIDE | Hikma Pharmaceuticals USA Inc. | c723fd27-214c-45f6-b170-a3b807ffab07 | 2024-04-12 | Warnings, Adverse reactions | 44YRR34555 |
| Sterile Water | WATER | Hikma Pharmaceuticals USA Inc. | 78ef7ad3-451d-43d0-a9b6-5cf0aadca003 | 2024-04-10 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | B. Braun Medical Inc. | 8fc8d87a-3951-4ac5-97df-c161ffc90475 | 2024-04-10 | Warnings, Adverse reactions | 059QF0KO0R |
| PREPARATION H Maximum Strength | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | Haleon US Holdings LLC | 7cc03d2e-e708-589a-d9bb-58ebbda989c0 | 2024-04-05 | Warnings | PDC6A3C0OX |
| Levetiracetam | LEVETIRACETAM | Aurobindo Pharma Limited | 2471ee03-d747-4113-86d0-1aa93c8f3eba | 2024-04-04 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Novadoz Pharmaceuticals LLC | 484e8d8f-be40-46f8-a509-d1bbdbbd2981 | 2024-04-04 | Warnings, Adverse reactions | 44YRR34555 |
| VAXR HC | THUJA OCCIDENTALIS, MEZEREUM, SILICEA, CALCAREA CARBONICA, MORBILLINUM, PAROTIDINUM, PERTUSSINUM, RUBELLA NOSODE, TETANUS TOXIN, CARCINOSIN, ANTIMONIUM CRUDUM, LEDUM PALUSTRE, THIMEROSAL, POLIOMYELITIS NOSODE | Deseret Biologicals, Inc. | fdf8d21a-2ae1-4842-abf3-737841995939 | 2024-04-03 | Warnings | ETJ7Z6XBU4 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | ed8e88d0-993e-4683-bdcf-31578130d3df | 2024-04-03 | Warnings, Adverse reactions | 387003 44YRR34555 |
| ANTICOAGULANT SODIUM CITRATE | TRISODIUM CITRATE DIHYDRATE | Baxter Healthcare Corporation | 7025a0f9-1a56-4416-a3a4-925d755aed90 | 2024-04-02 | B22547B95K | |
| Eye Wash | WATER | M-star (Hubei) Health&Care Products Co., Ltd. | 71706039-e250-4f08-9687-71b2928c4e46 | 2024-04-01 | Warnings | 059QF0KO0R |
| Motivation | DIOSCOREA VILLOSA, LECITHIN, SEPIA, VIOLA ODORATA, ADRENALINUM, LITHIUM CARBONICUM, THYROIDINUM (BOVINE), PLACENTA TOTALIS SUIS, GUAIACUM, SOLANUM TUBEROSUM, ANTIMONIUM CRUDUM, AURUM SULPHURATUM, BARYTA CARBONICA, CHININUM SULPHURICUM, CONIUM MACULATUM, GRAPHITES, LILIUM TIGRINUM, RHUS VENENATA, SELENIUM METALLICUM, ALUMINA | Deseret Biologicals, Inc. | c2bb0fb2-7ffa-4d16-8fff-b4c3dde966f4 | 2024-04-01 | Warnings | LMI26O6933 |
| Levetiracetam | LEVETIRACETAM IN SODIUM CHLORIDE | Eugia US LLC | e5eb4c89-8ee9-4474-9cb1-c3b3dc262a4a | 2024-04-01 | Warnings, Adverse reactions | 44YRR34555 |
| Clear Eyes Natural Tears | POLYVINYL ALCOHOL AND POVIDONE | Prestige Brands Holdings, Inc. | efba3eb0-798d-4635-b19b-4970e45b3cc9 | 2024-04-01 | Warnings | FZ989GH94E |
| Levetiracetam | LEVETIRACETAM | WG Critical Care, LLC | 62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926 | 2024-03-29 | Warnings, Adverse reactions | 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | Solco healthcare U.S., LLC | bc8644ed-3320-47b5-adf3-8b972bea8abd | 2024-03-28 | Warnings, Adverse reactions | 44YRR34555 |
| RV Illuminance Serum Tint Broad Spectrum 15 | FACE FOUNDATION WITH SPF | REVLON CONSUMER PR Consumer Products Corp | 132aab60-da19-7079-e063-6394a90a1d76 | 2024-03-27 | Warnings | 15FIX9V2JP |
| RV Illuminance Serum Tint Broad Spectrum 15 Amber | FACE FOUNDATION WITH SPF | REVLON CONSUMER PR Consumer Products Corp | 2a0ac71c-e53a-5ff9-e063-6394a90a4807 | 2024-03-27 | Warnings | 15FIX9V2JP |
| Levetiracetam | LEVETIRACETAM | Solco Healthcare US, LLC | 57f09129-7151-4a75-9d73-9dd32f74ba43 | 2024-03-27 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.